• Tidak ada hasil yang ditemukan

Ekspresi Matriks Metalloproteinase-9 Pada Polip Hidung Di Rsup H. Adam Malik Medan

N/A
N/A
Protected

Academic year: 2017

Membagikan "Ekspresi Matriks Metalloproteinase-9 Pada Polip Hidung Di Rsup H. Adam Malik Medan"

Copied!
4
0
0

Teks penuh

(1)

37 DAFTAR PUSTAKA

Allobid, I; Mullol, J. 2012. “Role of Medical Therapy in the Management of Nasal Polyps.”Curr Allergy Asthma Rep 12:144–153.

Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases. Romanian Journal of Morphology and Embryology 488 (4) : 323- 324.

Amalinei, C; Căruntu, I, D; Giuşcă, S, E; Bălan, R, A. 2010. “Matrix Metalloproteinases involvement in patologic conditions.” Romanian Journal of Morphology and Embryology 51 (2) : 215-218.

Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal polyposis.” American journal of rhinlogy & allergy 25, 291-298. Assanasen, P; Naclerio, R M. 2001. “ Medical and surgical management

of nasal polyps.” Nasal Polyps

Bachert, C. 2011. “Evidence- based management of nasal polyposis by intranasal corticosteroid: from the cause to the clinic.” Int arch allergy immunol, 155:309-321.

Belleguic, C; Corbel, M; Germain, N; Lena, H; Baichot, E; Delaval, P H. 2002. “Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients.” ClinExpAllergy 2002;32:217–23. Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9

(MMP-9) in allergic nasal polyps.” Acta histochemica 112 : 92-95. Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases

(MMPs).

Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007. “Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.” Allergy volume 62, issue 1, p.66-72.

Cincik, H; Erkul, E; Pinar, D; Ipcioglu, O; Gungor, A; Cekin, E; Cakmak, A. 2013. “Evaluation of MMP-9 and TIMP-1 Levels of the Patients with Nasal Polyposis After Corticosteroid Therapies.” Indian J Otolaryngol

Head Neck Surg. 2013 Aug; 65(Suppl 2): 445–449.

(2)

38

Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun 2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok, Bedah Kepala dan Leher. FK USU

Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli, M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in nasal polyps.” Italian journal of anatomy and embryology, vol 117, n. 2: 87.

Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008. The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med wkly;138 (45-46) : 684-688

Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role of extracellular matrix metalloproteinases and their inhibitors in allergic diseases.” Postep derm alergol, XXIX,5:384-389.

Lacroix, J S; Zheng, C G; Goytom, S H; Landis, B; Szalay-Quinodoz, I; Malis,D D. 2002. “Histological comparison of nasal polyposis in

black African, Chinese and Caucasian patients.” Rhinology,

40,118-121.

Lee, Y M; Kim, S S; Kim, H A; Suh, Y J; Lee, S K; Nahm, D H; Park, H S. 2003. “ Eosinophil inflammation of nasal polyp tissue: Relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-β1.” J korean med science; 18:97-102.

Lechapt-Zalcman, E; Coste, A; d'Ortho, M P; Frisdal, E; Harf, A; Lafuma, C; Escudier, E. 2001.” Increased expression of matrix metalloproteinase-9 in nasal polyps.” J pathol 2001 Feb;193(2):233-41.

Mudd, P A; Katial, R K; Alam, R; Hohensee, S; Ramakrishnan, V; Kingdom, T T. 2011.” Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in

nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis.” Ann Allergy Asthma Immunology.

(3)

39

Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟, Majalah Kedokteran Nusantara, vol.1, hal. 1-3.

Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed, vol 2, p. 1549-1557

Okada, S; Kita, H; George, T J; Gleich, G J; Leiferman, K M. 1997.” Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9.” AmJRespirCellMolBiol ;17:519–28.

Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010. “Epidemiologi of nasal polyps in: Nasal polyposis.” Springer- Verlag Berlin.

Polzehl, D; Moeller, P; Riechielmann, H; Perner, S. 2006. “Distinct features of chronic rhinosinusitis with and without nasal polyps.” DOI: 10.1111/j.1398-9995.2006.01132.

Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1, p.525-547

Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008. “Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis cell culture by interleukin5 and -13.” In vivo 22:415-422.

Schlosser, R J; Woodworth, B A. 2009. “Chronic Rhinosinusitis and Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck Surgery.” BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582.

Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate

semprot hidung dan metil prednisolon oral pada polip hidung dinilai dari perubahan jumlah sel radang dan stadium polip hidung.” repository.usu.ac.id/xmlui/handle/123456789/42402.

Shimizu, T; Kanai, K; Asano, K; Hisamitsu, T; Suzaki, H. 2005. “Suppression of matrix metalloproteinase production in nasal

(4)

40

fibroblasts by tranilast, an antiallergic agent, in vitro.” Mediator inflamm 14;2005(3):150-9.

Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.

Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis in: Current medical research and opinions, vol 23, no.9, p. 2135-46.

S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and their inhibitors in non- neoplastic otorhinolaryngological disease.” The journal of laryngology and otology 119.6: 436-42.

Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal polyps.” Allergology International, 54:39-4.

Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of metalloproteinases MMP-9 in antrochoanal polyps. American Journal of Rhinology 22 : 339-342

Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012. “Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis.” American journal of rhinology & allergy 26, e1-e4.

Wright, C. 2008. “Medical management of nasal polyposis.” Grand rounds presentation, UTMB, Dept. Of Otolaryngology.

Referensi

Dokumen terkait

Berdasarkan pada uraian latar belakang masalah, maka yang menjadi rumusan masalah dalam penelitian ini adalah, apakah peningkatan kemampuan komunikasi matematis

Rancangan sistem yang diusulkan dalam studi ini masih menggunakan konsep programa linear obyektif tunggal khususnya pada perencanaan produksi agregat sehingga masih bisa

Penelitian ini bertujuan untuk mengetahui:(1)manakah yang memberikanprestasi belajar lebih baik antara siswa yang dikenakan model pembelajaran kooperatif tipe TGT berbantuan

Pada indikator pertama, ketiga, dan keempat tidak terlihat adanya perbedaan pada siswa FI1 dan FI2, yaitu dalam menginterpretasikan ide matematis dapat memahami masalah

Based on the results presented, it is concluded that funnel card distribution pattern produced significant lowest inventory cost and bowl, inverted bowl, reversed funnel and

Berdasarkan hasil pengamatan waktu standar didapatkan bahwa waktu standar operator I adalah 0,0577 dan waktu standar operator II adalah 0,0566 rata- rata operator adalah 0,0572

Pada siklus II ini kegiatan In House Training (IHT) melalui mengamati tayangan vidio pembelajaran peneliti mengawali menyampaikan materi pembelajaran tematik terpadu

Namun untuk lebih jelasnya, para investor harus lebih teliti membaca laporan keuangan perusahaan farmasi sebagai analisis fundamental dalam menentukan perusahaan